Recent Updates
Recently added Catalysts
KYMR Positive Sentiment Score: 75/100

Kymera Therapeutics to Present in Fireside Chat at the Guggenheim Healthcare Conference

Wednesday, January 31, 2024 1 min read
Key Takeaway: Kymera Therapeutics, a clinical-stage biopharmaceutical company, will participate in a fireside chat at the Guggenheim 6th Annual Biotechnology Conference in New York on February 7, 2024. This event highlights Kymera's advancements in targeted protein degradation technologies. A live webcast of the discussion will be available, along with an archived replay post-event, enhancing investor accessibility to company updates.

Market Sentiment Analysis

POSITIVE FACTORS

  • Kymera Therapeutics is participating in a significant healthcare conference.
  • The company is advancing a new class of medicines using targeted protein degradation.
  • Live webcasts allow for broader investor engagement and transparency.

Full Press Release Details

WATERTOWN, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced that the Company will participate in a fireside chat at the Guggenheim 6th Annual Biotechnology Conference in New York, NY on February 7, 2024, at 9:30 a.m. ET.
A live webcast of the fireside chat will be available under “News and Events” in the Investors section of the Company’s website at www.kymeratx.com. A replay of the webcast will be archived and available following the event.
About Kymera Therapeutics
Investor Contact: Media Contact:
Justine Koenigsberg Todd Cooper
Vice President, Investor Relations Senior Vice President, Corporate Affairs
investors@kymeratx.com media@kymeratx.com
857-285-5300 857-285-5300

Frequently Asked Questions

When will Kymera Therapeutics participate in the biotechnology conference?

Kymera Therapeutics will participate on February 7, 2024, at 9:30 a.m. ET.

Where can I watch the live webcast of the fireside chat?

The live webcast will be available in the 'News and Events' section on their website.

Will there be a replay of the fireside chat available?

Yes, a replay of the webcast will be archived and accessible after the event.

What does Kymera Therapeutics specialize in?

Kymera Therapeutics focuses on developing targeted protein degradation therapies.

Who should I contact for investor inquiries at Kymera?

For investor inquiries, contact Justine Koenigsberg at investors@kymeratx.com.

Tags: KYMR Viatris Investor Conferences Healthcare Kymera Therapeutics Guggenheim Conference targeted protein degradation biopharmaceutical clinical-stage
Last updated: Jan 31, 2024